C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/113 (2010.01) A61K 31/713 (2006.01) C12N 15/63 (2006.01)
Patent
CA 2761142
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of Tristetraproline (TTP), in particular, by targeting natural antisense polynucleotides of Tristetraproline (TTP). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of TTP.
La présente invention porte sur des oligonucléotides antisens qui modulent l'expression et/ou la fonction de la tristétraproline (TTP), en particulier, par ciblage de polynucléotides antisens naturels de la tristétraproline (TTP). L'invention porte également sur l'identification de ces oligonucléotides antisens et sur leur utilisation pour le traitement de maladies et de troubles associés à l'expression de TTP.
Collard Joseph
Khorkova Sherman Olga
Norton Rose Canada S.e.n.c.r.l.,s.r.l./llp
Opko Curna Llc
LandOfFree
Treatment of tristetraproline (ttp) related diseases by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of tristetraproline (ttp) related diseases by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of tristetraproline (ttp) related diseases by... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1603416